Articles published by Mirum Pharmaceuticals, Inc.
![](https://mms.businesswire.com/media/20221118005128/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
November 18, 2022
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20221109005330/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
November 09, 2022
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20221107005899/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20221101006246/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20221030005049/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20221024005361/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20221018005542/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20221013005969/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20221012005501/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20221010005820/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2022
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20221005005359/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20220911005098/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2022
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20220830005960/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20220812005406/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20220810005857/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 10, 2022
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20220809006130/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20220809006057/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20220804005911/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
August 04, 2022
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20220728005326/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20220708005567/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20220624005088/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20220624005098/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20220613005346/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20220610005620/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20220606005420/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20220523005396/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20220518006159/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20220510006503/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20220505005401/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.